Русский
Cardiovascular pathology detected during follow-up care of people living with HIV adherent to antiretroviral therapy
DOI: https://dx.doi.org/10.18565/epidem.2025.15.3.41-47
Shilov A M., Pokrovskaya A.V.
1) Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; 2) Patrice Lumumba Peoples’ Friendship University of Russia, Moscow, Russia
Materials and methods. The age profile of CVDs detected by a general practitioner and a cardiologist was analyzed using the medical records of 400 PLHIV receiving foloow-up care at the Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being. The age discrimination ability for the detected nosologies was determined. The lipid profile of PLHIV adherent to modern antiretroviral therapy (ART) regimens was characterized, CV risks were calculated using the SCORE2 and SCORE2-OP scales, and the obtained data were compared with the general population data. The effect of a cardiologist consultation on adherence to antihypertensive and lipid-lowering therapy was studied.
Results. It was determined that the age profile of CVDs in PLHIV adherent to ART does not differ from that in the general population. At the same time, the addition of a cardiologist consultation to follow-up care increases the detection of CVD compared to a protocol that includes only examinations by a general practitioner. The lipid profile in PLHIV differs from the general population by higher concentrations of low-density lipoproteins and lower triglyceride levels. Taking a number of ART regimens is associated with abnormal concentrations of individual plasma lipid fractions. Patients who were consulted by a cardiologist had significantly higher adherence to antihypertensive and lipid-lowering therapy; such a relationship was not determined for consultations with a general practitioner.
Conclusion. The use of estimated cardiovascular risk scales by attending physician provides timely identification of indications for consultation with a cardiologist among PLHIV over 40 years of age. An infectious disease specialist can correct these risks taking into account the proatherogenic potential of ART. Individualization of screening for concomitant pathology of PLHIV allows for improving their quality of life and reducing treatment costs.
Literature
1. Swinkels H.M., Nguyen A.D., Gulick P.G. HIV and AIDS. Treasure Island (FL): StatPearls Publishing; 2025. 68 p. 2. Покровский В.В., Ладная Н.Н., Соколова Е.В. ВИЧ-инфекция. Информационный бюллетень № 48. М., 2024. http://www.hivrussia.info/wp-content/uploads/2024/11/hiv-infection-info-bulletin-48.pdf Pokrovsky V.V., Ladnaya N.N., Sokolova E.V. [HIV infection. Information bulletin №. 48]. Moscow, 2024. (In Russ.). http://www.hivrussia.info/wp-content/uploads/2024/11/hiv-infection-info-bulletin-48.pdf 3. Smit M., Brinkman K., Geerlings S., Smit C., Thyagarajan K., Sighem A. et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect. Dis. 2015; 15(7): 810–818. DOI: 10.1016/S1473-3099(15)00056-0 4. McGettrick P., Barco E.A., Mallon P.W.G. Ageing with HIV. Healthcare 2018; 6(1): 17. DOI: 10.3390/healthcare6010017 5. Ghandakly E., Moudgil R., Holman K. Cardiovascular disease in people living with HIV: Risk assessment and management. Cleve Clin. J. Med. 2025; 92(3): 159–167. DOI: 10.3949/ccjm.92a.24055 6. Zhu S., Wang W., He J., Duan W., Ma X. Higher cardiovascular disease risks in people living with HIV: A systematic review and meta-analysis. J. Glob. Health 2024; 14: 04078. DOI: 10.7189/jogh.14.04078 7. Shah A.S.V., Stelzle D., Lee K.K., Beck E.J., Alam S., Clifford S. et al. Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis. Circulation 2018; 138(11): 1100–1112. DOI: 10.1161/CIRCULATIONAHA. 117.033369 8. So-Armah K., Benjamin L.A., Bloomfield G.S., Feinstein M.J., Hsue P., Njuguna B. et al. HIV and cardiovascular disease. Lancet HIV 2020; 7(4): e279–e293. DOI: 10.1016/S2352-3018(20)30036-9 9. Lang R., Humes E., Hogan B., Lee J., D’Agostino R., Massaro J. et al. Evaluating the Cardiovascular risk in an Aging Population of people with HIV: the impact of Hepatitis C Virus Coinfection. J. Am. Heart. Association 2022; 11(19): e026473. DOI: 10.1161/JAHA.122.026473 10. Jaschinski N., Greenberg L., Neesgaard B., Miró J.M., Grabmeier-Pfistershammer K., Wandeler G. et al. Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV. AIDS 2023; 37(3): 467–475. DOI: 10.1097/QAD.0000000000003373 11. Yuvaraj A., Mahendra V.S., Chakrapani V., Yunihastuti E., Santella A.J., Ranauta A. et al. HIV and stigma in the healthcare setting. Oral Dis. 2020; 26(Suppl. 1): 103–111. DOI: 10.1111/odi.13585 12. Кобалава Ж.Д., Конради А.О., Недогода С.В., Шляхто Е.В., Арутюнов Г.П., Баранова Е.И. и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2024. Российский кардиологический журнал 2024; 29(9): 6117. DOI: 10.15829/1560-4071-2024-6117 Kobalava Zh.D., Konradi A.O., Nedogoda S.V., Shlyakhto E.V., Arutyunov G.P., Baranova E.I. et al. [Arterial hypertension in adults. Clinical guidelines Clinical practice guidelines 2024]. Russian Journal of Cardiology 2024; 29(9): 6117. (In Russ.). DOI: 10.15829/1560-4071-2024-6117 13. Ежов М.В., Кухарчук В.В., Сергиенко И.В., Алиева А.С., Анциферов М.Б., Аншелес А.А. и др. Нарушения липидного обмена. Клинические рекомендации 2023. Российский кардиологический журнал. 2023; 28(5): 5471. DOI:10.15829/1560-4071-2023-5471 Ezhov M.V., Kukharchuk V.V., Sergienko I.V., Alieva A.S., Antsiferov M.B., Ansheles A.A. et al. [Disorders of lipid metabolism. Clinical Guidelines 2023]. Russian Journal of Cardiology 2023; 28(5): 5471. (In Russ.). DOI: 10.15829/1560-4071-2023-5471 14. Барбараш О.Л., Карпов Ю.А., Панов А.В., Акчурин Р.С., Алекян Б.Г., Алехин М.Н. и др. Стабильная ишемическая болезнь сердца. Клинические рекомендации 2024. Российский кардиологический журнал 2024; 29(9): 6110. DOI: 10.15829/1560-4071-2024-6110 Barbarash O.L., Karpov Yu.A., Panov A.V., Akchurin R.S., Alekyan B.G., Alekhin M.N. et al. [Stable coronary artery disease. Clinical guidelines 2024]. Russian Journal of Cardiology 2024; 29(9): 6110. (In Russ.). DOI: 10.15829/1560-4071-2024-6110 15. Аверков О.В., Арутюнян Г.К., Дупляков Д.В., Константинова Е.В., Никулина Н.Н., Шахнович Р.М. Острый инфаркт миокарда с подъемом сегмента ST электрокардиограммы. Клинические рекомендации 2024. Российский кардиологический журнал 2025; 30(3): 6306. DOI: 10.15829/1560-4071-2025-6306 Averkov O.V., Harutyunyan G.K., Duplyakov D.V., Konstantinova E.V., Nikulina N.N., Shakhnovich R.M. et al. [Acute myocardial infarction with ST-segment elevation on the electrocardiogram. Clinical guidelines 2024]. Russian Journal of Cardiology 2025; 30(3): 6306. (In Russ.). DOI: 10.15829/1560-4071-2025-6306 16. Рубцов П.П., Бокерия Л.А. Эпидемиология аритмий у взрослых пациентов с врожденными пороками сердца. Анналы аритмологии 2021; 18(4): 223–229. DOI: 10.15275/annaritmol.2021.4.3 Rubtsov P.P., Bockeria L.A. [Arrhythmias prevalence in adult patients with congenital heart disease]. Annaly aritmologii 2021; 18(4): 223–229. (In Russ.). DOI: 10.15275/annaritmol.2021.4.3 17. Мешков А.Н., Ершова А.И., Деев А.Д. Метельская В.А., Жернакова Ю.В., Ротарь О.П. и др. Распределение показателей липидного спектра у мужчин и женщин трудоспособного возраста в Российской Федерации: результаты исследования ЭССЕ-РФ за 2012–2014. Кардиоваскулярная терапия и профилактика 2017; 16(4): 62–67. DOI 10.15829/1728-8800-2017-4-62-67 Meshkov A.N., Ershova A.I., Deev A.D., Metelskaya V.A., Zhernakova Yu.V., Rotar O.P. et al. [Distribution of lipid profile values in economically active men and women in Russian Federation: results of the ESSE-RF study for the years 2012–2014[. Cardiovascular Therapy and Prevention 2017; 16(4): 62–67. (In Russ.). DOI: 10.15829/1728-8800-2017-4-62-67 18. Покровский В.В., Юрин О.Г., Кравченко А.В., Беляева В.В., Ермак Т.Н., Канестри В.Г. и др. Рекомендации по лечению ВИЧ-инфекции и связанных с ней заболеваний, химиопрофилактике заражения ВИЧ. Эпидемиол. инфекц. болезни. Актуал. вопр. 2024; 14(4, приложение). 108 с. Pokrovsky V.V., Yurin O.G., Kravchenko A.V., Belyaeva V.V., Ermak T.N., Kanestry V.G. et al. [Recommendations for the treatment of HIV infection and related diseases, chemoprophylaxis of HIV infection]. Epidemiology and infectious diseases. Current item 2024; 14(4, application). 108 р. (In Russ.). 19. ВИЧ-инфекция у взрослых. Клинические рекомендации. Национальная ассоциация специалистов по профилактике, диагностике и лечению ВИЧ-инфекции, Национальная вирусологическая ассоциация, 2024. https://nvarus.ru/wp-content/uploads/2025/02/kr79_2.pdf [HIV infection in adults. Clinical guidelines]. National Association of Specialists in the Prevention, Diagnosis and Treatment of HIV Infection, National Virological Association, 2024. (In Russ.). https://nvarus.ru/wp-content/uploads/2025/02/kr79_2.pdf 20. Заирова А.Р., Рогоза А.Н., Ощепкова Е.В., Шальнова С.А., Трубачева И.А., Кавешников В.С. и др. Стратификация сердечно-сосудистого риска с использованием шкалы SCORE2 в популяционной выборке взрослого городского населения и оценка ее эффективности по результатам 5-летнего наблюдения. Кардиоваскулярная терапия и профилактика 2025; 24(1): 4184. DOI: 10.15829/1728-8800-2025-4184 Zairova A.R., Rogoza A.N., Oshchepkova E.V., Shalnova S.A., Trubacheva I.A., Kaveshnikov V.S. et al. [SCORE2 cardiovascular risk stratification of an urban adult population sample and evaluation of its effectiveness based on 5-year follow-up]. Cardiovascular Therapy and Prevention 2025; 24(1): 4184. (In Russ.). DOI: 10.15829/1728-8800-2025-4184
About the Autors
Andrey M. Shilov, Graduate student, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; Assistent, Department of Infectious Diseases with Courses of Epidemiology and Phthisiology, Medical Institute, Patris Lumumba Peoples’ Friendship University of Russia, Moscow, Russia; sh_andrey_max@mail.ru, https://orcid.org/0009-0000-7966-9708.
Anastasia V. Pokrovskaya, MD, Senior Researcher, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; Professor, Department of Infectious Diseases with Courses of Epidemiology and Phthisiology, Medical Institute, Patris Lumumba Peoples’ Friendship University of Russia, Moscow, Russia; pokrovskaya@cmd.su; https://orcid.org/0000-0002-2677-0404
Similar Articles
